The Burrill Report (August 2, 2010): The IPO Market Sizzles - In China (.MP3,8.05 Mb)

Wondering if the IPO window is open? Well there’s no doubt about it if you are talking about the IPO market in China. The life sciences sector has raised $6.1 billion through initial public offerings in the past 12 months, far outpacing the activity in the United States. And, despite the collapse of Charles River's $1.6 billion acquisition of Wuxi, M&A activity is growing. We spoke to Greg Scott, president and founder of the consulting firm ChinaBio and publisher of ChinaBio Today, about the thriving IPO market for life sciences companies there, how that’s evolved over the past year and what the outlook is moving forward.